aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Janssen, a pharmaceutical company under Johnson & Johnson, was founded with the mission to transform individual lives by fundamentally changing how diseases are managed, interpreted, and prevented. Based in Cologno Monzese, Italy, Janssen focuses on bringing innovative solutions and advancing science to benefit patients globally. The company collaborates with informed and empowered patients to design accessible and effective healthcare solutions, ensuring that the best available treatments are affordable and reach those in need.
Notable figures affiliated with Janssen include its association with Johnson & Johnson, a global leader in healthcare. Janssen has achieved significant milestones in developing treatments for various diseases, contributing to improved patient outcomes worldwide. The company's impact is evident in its commitment to innovation and accessibility, making substantial strides in healthcare by providing effective and affordable medicines.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Pharmaceuticals
Technology
Biotech
Tags
Healthtech, Pharmaceuticals
Model Types
Retail
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Consumers
Geographic Exposure
Global
When was Janssen founded?
Janssen was founded in 1953.
Where is Janssen’s headquarters located?
Janssen’s headquarters is located in DE, US.
How many employees does Janssen have?
Janssen has 255 employees as of Feb 4, 2024.
Add Comparison
Total Employees Over Time
255
As of Feb 2024
Janssen Address
Delaware
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts